Skip to content
Disclosery

EXANE DERIVATIVES: QURE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on QURE, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 8 QURE shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 8 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $149.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 8 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $145.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 8 shares
    Change vs previous 13F -4,721 shares

    <0.01% of the 13F portfolio, value $166.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 4,729 shares
    Change vs previous 13F -46 shares

    0.04% of the 13F portfolio, value $151,370.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 4,775 shares
    Change vs previous 13F +825 shares

    0.03% of the 13F portfolio, value $132,503.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 3,950 shares
    Change vs previous 13F +1,593 shares

    0.04% of the 13F portfolio, value $133,069.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 2,357 shares
    Change vs previous 13F not available

    0.03% of the 13F portfolio, value $85,154.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).